About
Antibody-drug Conjugates
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
438
By Phase
PHASE1: 2
By Status
RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07127874Lead Sponsor
A Study of PHN-012 in Patients With Advanced Solid Tumors
PHASE1Recruiting
165 participants
Started: Sep 23, 2025 · Completed: May 31, 2028
NCT06457997Lead Sponsor
A Study of PHN-010 in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
273 participants
Started: Jul 1, 2024 · Completed: Jul 31, 2027
Locations (1)
Headquarters
Harpenden, UK
Map
Loading map...